KPIs & Operating Metrics(New)
Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Account PayablesChange in Accured ExpensesChange in Acquisitions & DivestmentsChange in CashChange in InventoryChange in ReceivablesDepreciation & Amortization (CF)Free Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesOther financing activitiesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Rigel Pharmaceuticals (RIGL) Amortizatization of Intangibles: 2016-2024

Historic Amortizatization of Intangibles for Rigel Pharmaceuticals (RIGL) over the last 9 years, with Dec 2024 value amounting to $709,000.

  • Rigel Pharmaceuticals' Amortizatization of Intangibles rose 576.81% to $467,000 in Q3 2025 from the same period last year, while for Sep 2025 it was $1.2 million, marking a year-over-year increase of 70.71%. This contributed to the annual value of $709,000 for FY2024, which is 48.02% up from last year.
  • Rigel Pharmaceuticals' Amortizatization of Intangibles amounted to $709,000 in FY2024, which was up 48.02% from $479,000 recorded in FY2023.
  • In the past 5 years, Rigel Pharmaceuticals' Amortizatization of Intangibles ranged from a high of $709,000 in FY2024 and a low of -$287,000 during FY2021.
  • Moreover, its 3-year median value for Amortizatization of Intangibles was $479,000 (2023), whereas its average is $417,000.
  • In the last 5 years, Rigel Pharmaceuticals' Amortizatization of Intangibles crashed by 335.25% in 2021 and then skyrocketed by 660.32% in 2023.
  • Yearly analysis of 5 years shows Rigel Pharmaceuticals' Amortizatization of Intangibles stood at $122,000 in 2020, then crashed by 335.25% to -$287,000 in 2021, then skyrocketed by 121.95% to $63,000 in 2022, then skyrocketed by 660.32% to $479,000 in 2023, then spiked by 48.02% to $709,000 in 2024.